Streamlining Cigna Prior Authorization for Infectious Disease Treatments

Efficiently managing Cigna prior authorization for infectious disease treatments is critical for patient access and revenue cycle integrity. Klivira's platform automates the complex workflows associated with high-cost ID therapies.

Infectious disease specialists frequently prescribe high-cost antivirals, antifungals, and manage complex outpatient parenteral antibiotic therapy (OPAT) regimens. These treatments are often subject to stringent prior authorization requirements by Cigna Healthcare, necessitating precise documentation and timely submission across multiple channels. Navigating Cigna's specific medical necessity criteria and submission pathways for these specialized therapies can be a significant operational challenge.

Navigating Cigna's Prior Authorization Channels for Infectious Disease Therapies

Cigna Healthcare directs medical-benefit prior authorization submissions, including for OPAT and certain medical-benefit antivirals, through its CignaforHCP.com provider portal. For pharmacy-benefit infectious disease medications, Express Scripts, operating under the Evernorth brand, manages prior authorizations. This includes retail pharmacy submissions via CoverMyMeds and Surescripts ePA platforms, as well as specialty pharmacy PAs through Accredo for complex injectables.

Key Infectious Disease Categories Requiring Cigna Prior Authorization

High-cost antivirals (e.g., Hepatitis C, HIV regimens)
Specialized antifungals
Outpatient Parenteral Antibiotic Therapy (OPAT)
Complex combination antibiotic therapies
Immunomodulators used in specific infectious disease contexts

Understanding Cigna's Medical Necessity Criteria for ID Treatments

Cigna Healthcare publishes its coverage policies and medical-necessity guidelines on its public provider site, structured by topic and versioned with effective dates. For infectious disease treatments, these policies outline specific clinical indications, diagnostic requirements, and often step-therapy protocols that must be met. Klivira's automation platform integrates with these policy libraries to help ensure submissions align with Cigna's criteria.

Expediting Turnaround Times for Cigna Infectious Disease PAs

Prior authorization turnaround times for Cigna's commercial plans are governed by state insurance regulations, which vary significantly. For Cigna's Medicare Advantage plans, the CMS-0057-F rule mandates specific timeframes: 72 hours for standard and 24 hours for expedited requests. Klivira helps optimize the submission process to meet these critical deadlines, reducing delays in patient care for infectious disease conditions.

Addressing Cigna Prior Authorization Denials for ID Specialists

Common denial reasons for infectious disease prior authorizations with Cigna Healthcare often include insufficient clinical documentation to support medical necessity, failure to meet step-therapy requirements, or site-of-service mismatches. Pharmacy benefit denials through Evernorth's Express Scripts may also relate to non-formulary medications. Klivira's system helps identify and address these patterns, facilitating more complete initial submissions and streamlined appeals.

Leveraging Da Vinci PAS for Cigna Infectious Disease Workflows

Cigna Healthcare participates in the HL7 Da Vinci Project, signaling a commitment to electronic prior authorization (ePA) standards like Prior Authorization Support (PAS). While specific production conformance requires verification, Express Scripts has long-established ePA capabilities through CoverMyMeds and Surescripts. Klivira's platform is designed to align with these evolving electronic standards, enhancing the efficiency of Cigna prior authorization for infectious disease.

Frequently asked questions

How do I submit an expedited PA for an urgent infectious disease case to Cigna?

Expedited prior authorization requests for urgent infectious disease cases should be submitted via CignaforHCP.com for medical benefits or through Express Scripts' designated channels for pharmacy benefits, clearly indicating the urgent nature. For Medicare Advantage plans, CMS-0057-F mandates a 24-hour turnaround for expedited requests.

What are the primary channels for Cigna pharmacy benefit PAs for infectious disease drugs?

For pharmacy benefit prior authorizations, Cigna's PBM, Express Scripts (under Evernorth), processes requests. Submissions can be made through the Express Scripts provider portal or via ePA platforms like CoverMyMeds and Surescripts. Specialty infectious disease medications are often handled through Accredo, also an Evernorth company.

Where can I find Cigna's medical necessity criteria for high-cost antivirals?

Cigna Healthcare publishes its comprehensive coverage policies and medical necessity criteria on its public provider website. You should refer to the specific policy number and effective date relevant to the antiviral medication in question to ensure compliance with the latest guidelines.

Does Klivira integrate with CignaforHCP for infectious disease prior authorizations?

Yes, Klivira integrates with EMRs and connects to payer portals like CignaforHCP.com to automate the submission and tracking of medical benefit prior authorizations, including those for infectious disease treatments like OPAT. This streamlines the workflow and reduces manual data entry.

What are common reasons for Cigna PA denials for infectious disease treatments?

Common denial reasons include insufficient clinical documentation to establish medical necessity, failure to demonstrate adherence to Cigna's step-therapy requirements, or lack of supporting evidence for the requested site of service. Pharmacy benefit denials may also occur due to formulary restrictions via Express Scripts.